{"meta":{"query_hash":"2f0cc07a5f23","filters":{"venue":"International Journal of Drug Regulatory Affairs"},"cohort_total":19,"direct_labels_cover":0,"predictions_cover":19,"exported":19,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/2f0cc07a5f23","api":"https://metacan.xera.ac/api/v1/cohort?venue=International+Journal+of+Drug+Regulatory+Affairs"},"results":[{"id":"W2183209710","doi":"10.22270/ijdra.v2i2.130","title":"A PRAGMATIC WAY TO SUSTAIN IN GENERIC PHARMA ENVIRONMENT: PLCM THROUGH REGULATORY STRATEGIES","year":2018,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Scope (computer science); Profitability index; Business; Quality (philosophy); Product (mathematics); Sustainability; Preference; Marketing; Work (physics); Competitive advantage; Process management; Risk analysis (engineering); Economics; Computer science; Engineering; Finance","score_opus":0.025933142335729867,"score_gpt":0.28150899596129453,"score_spread":0.2555758536255647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2183209710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95497376,0.0011316371,0.0010459145,0.0067637335,0.0015743251,0.00019115584,0.00007270872,0.000014774082,0.034232017],"genre_scores_gemma":[0.9960975,0.00020893871,0.0010725039,0.0009089546,0.0010763515,0.00000843293,0.000003931405,0.00003356017,0.0005897921],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.997917,0.00004505901,0.0012486249,0.00029323713,0.00015273958,0.0003433402],"domain_scores_gemma":[0.9986523,0.000068989684,0.0007320771,0.00025382926,0.000096527605,0.00019628827],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00097144063,0.00020850197,0.00041766276,0.00054436724,0.00005317392,0.00013479593,0.00076512026,0.0000784339,0.0015045663],"category_scores_gemma":[0.00007267164,0.00023202354,0.00018784209,0.00015342003,0.00017942254,0.0008661583,0.00014541179,0.0002546972,0.00046326633],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000543895,0.0007305868,0.01066522,0.000070067,0.0009640499,0.00014331452,0.012793758,0.013549829,0.0018900852,0.91971356,0.03430475,0.00463087],"study_design_scores_gemma":[0.0047512087,0.000301228,0.042027377,0.00017774291,0.0000348275,0.00019801974,0.0043243403,0.0053974004,0.0045603113,0.272177,0.6650456,0.0010049166],"about_ca_topic_score_codex":0.000032903656,"about_ca_topic_score_gemma":0.00001919678,"teacher_disagreement_score":0.6475366,"about_ca_system_score_codex":0.0006206882,"about_ca_system_score_gemma":0.000098015145,"threshold_uncertainty_score":0.9994082},"labels":[],"label_agreement":null},{"id":"W2821537775","doi":"10.22270/ijdra.v6i2.236","title":"Regulatory requirements for Drug master file in context to Canada and Australia","year":2018,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Health Canada","keywords":"Legislation; Context (archaeology); Terminology; Drug; Business; Quality (philosophy); Product (mathematics); Computer science; Political science; Pharmacology; Medicine; Law; Biology","score_opus":0.05655171049066777,"score_gpt":0.2988763481879289,"score_spread":0.24232463769726115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2821537775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99001896,0.00018445415,0.00004468629,0.0047029634,0.0019795727,0.00015498266,0.0007018607,0.0000033550418,0.002209183],"genre_scores_gemma":[0.994777,0.0000123362925,0.00035396148,0.001784901,0.0006641757,0.000008327753,0.000007914018,0.000017558788,0.0023738071],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985987,0.000013553864,0.00085173507,0.00021313017,0.00008981899,0.00023304374],"domain_scores_gemma":[0.99895483,0.00008471554,0.0004555639,0.00013404265,0.00015877694,0.00021208408],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058375957,0.00013088294,0.0002934274,0.0003007966,0.000036446894,0.00006175239,0.00037520274,0.000041498806,0.0010628407],"category_scores_gemma":[0.00010871431,0.000148942,0.00008437106,0.000061819395,0.00007927412,0.00023150246,0.000074386284,0.00011609877,0.000037205937],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008616017,0.00022493472,0.1126641,0.000060875333,0.0007763158,0.000056536548,0.003913875,0.00028174446,0.00032697723,0.1393346,0.7337705,0.0077279443],"study_design_scores_gemma":[0.0036100869,0.00012828584,0.15818821,0.00018847246,0.000014648328,0.000048307655,0.0009091173,0.0008322592,0.0022841115,0.022516401,0.8107478,0.0005323257],"about_ca_topic_score_codex":0.011841508,"about_ca_topic_score_gemma":0.11450073,"teacher_disagreement_score":0.116818205,"about_ca_system_score_codex":0.000476729,"about_ca_system_score_gemma":0.00013622208,"threshold_uncertainty_score":0.99985033},"labels":[],"label_agreement":null},{"id":"W2883638496","doi":"10.22270/ijdra.v3i4.172","title":"DMF FILING IN US, EUROPE AND CANADA","year":2018,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Confidentiality; Drug; Discretion; Business; Product (mathematics); Process (computing); Computer science; Internet privacy; Database; Law; Computer security; Political science; Pharmacology; Medicine; Operating system","score_opus":0.007224715325814822,"score_gpt":0.25728031795722656,"score_spread":0.25005560263141174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883638496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828043,0.00030528483,0.00004332032,0.013611636,0.0012441053,0.000042818687,0.0000033625113,0.000004256938,0.0019409282],"genre_scores_gemma":[0.9978514,0.000075861804,0.00039301123,0.00046642098,0.00083699793,2.4398506e-7,0.0000034365203,0.000009183442,0.0003634715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872756,0.000033183027,0.0003763543,0.00009581374,0.0006683364,0.00009876868],"domain_scores_gemma":[0.9990715,0.000050182956,0.00018731007,0.00007086429,0.00048288025,0.00013727682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043862802,0.00007305105,0.00014813468,0.00017336455,0.00002561177,0.000015888692,0.000117416064,0.00005656818,0.00007938111],"category_scores_gemma":[0.00010401346,0.000056930872,0.000035549223,0.00008482868,0.00031176358,0.00009114233,0.000039172686,0.00024680735,0.000001302148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043639303,0.0012028428,0.56956255,0.0003989764,0.0025110247,0.0067970646,0.008402244,0.00048817514,0.062142678,0.04034495,0.0834521,0.22033349],"study_design_scores_gemma":[0.0037389735,0.00023951328,0.87888587,0.0010448325,0.00006411727,0.001632164,0.0010876668,0.001956556,0.0057714917,0.0015327936,0.103827715,0.00021828692],"about_ca_topic_score_codex":0.008244515,"about_ca_topic_score_gemma":0.05413344,"teacher_disagreement_score":0.30932337,"about_ca_system_score_codex":0.00014856075,"about_ca_system_score_gemma":0.00061816006,"threshold_uncertainty_score":0.9983597},"labels":[],"label_agreement":null},{"id":"W2978147562","doi":"10.22270/ijdra.v7i3.341","title":"Regulatory architecture of biosimilars in Singapore: A critical overview","year":2019,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Business; Biological drugs; Product (mathematics); Agency (philosophy); Medicine; Clinical trial; Traditional medicine; Disease","score_opus":0.013321512832161105,"score_gpt":0.29787116975175737,"score_spread":0.28454965691959627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978147562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97341025,0.011052544,0.000136912,0.0077631003,0.004259076,0.00017112502,0.00004651263,0.000016776972,0.0031436973],"genre_scores_gemma":[0.99743503,0.00012246828,0.0015182409,0.00037771862,0.000098707445,9.1817975e-7,0.0000035433297,0.000016911215,0.00042646955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979881,0.00033989773,0.00092880183,0.00022488864,0.00026437046,0.00025391346],"domain_scores_gemma":[0.9983731,0.00046437958,0.0004455396,0.00025749422,0.00040608365,0.000053434873],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011630489,0.0001928552,0.00052507606,0.00045272615,0.000021095042,0.000015078434,0.00063616084,0.00024871825,0.0011547004],"category_scores_gemma":[0.00033654674,0.00015368257,0.00035787828,0.0001777646,0.00042481037,0.00015761252,0.00012028224,0.0005813497,0.000021727441],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033651185,0.0021111765,0.084076256,0.0004564873,0.002809864,0.00037493024,0.002067261,0.0005498828,0.7755737,0.06140202,0.020985464,0.046227872],"study_design_scores_gemma":[0.011645158,0.0012313966,0.2555232,0.004574295,0.00047543016,0.0028012348,0.0037553536,0.00009855743,0.57756436,0.034765005,0.106187224,0.0013788192],"about_ca_topic_score_codex":0.0000043513483,"about_ca_topic_score_gemma":0.000007654693,"teacher_disagreement_score":0.19800934,"about_ca_system_score_codex":0.00010795705,"about_ca_system_score_gemma":0.00016231848,"threshold_uncertainty_score":0.99975836},"labels":[],"label_agreement":null},{"id":"W2978302277","doi":"10.22270/ijdra.v7i3.327","title":"Intellectual Property Right in India- A Review","year":2019,"lang":"en","type":"review","venue":"International Journal of Drug Regulatory Affairs","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure","funders":"","keywords":"Business; Intellectual property; Order (exchange); Quality (philosophy); Process (computing); Risk analysis (engineering); Marketing; Computer science; Law; Finance; Political science","score_opus":0.07087529224784708,"score_gpt":0.3310711663333638,"score_spread":0.2601958740855167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978302277","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002063362,0.9647783,0.000007711682,0.00075886096,0.0026145973,0.00043261825,0.00016514139,0.000007384144,0.03121474],"genre_scores_gemma":[0.0005654407,0.995933,0.00005454195,0.00075549504,0.0006969799,0.00001675011,0.000024683166,0.00006128333,0.0018918518],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960882,0.000095767566,0.002969302,0.00039329063,0.00014447849,0.0003089319],"domain_scores_gemma":[0.9964962,0.00028268268,0.0025724513,0.0003419216,0.00013206889,0.00017469942],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001676112,0.00039489142,0.0024653033,0.0011878364,0.000020846932,0.00008734457,0.0015239549,0.00021954051,0.0019425252],"category_scores_gemma":[0.00043657245,0.00030502898,0.0011097033,0.00027301683,0.00008819386,0.00036873476,0.00019749458,0.00094928907,0.0015765305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007489903,0.0006376797,0.00015773776,0.027172979,0.0033454048,0.0003877089,0.00065893395,0.000025880652,2.0841323e-7,0.07365856,0.15656507,0.73731494],"study_design_scores_gemma":[0.00043220943,0.000026637665,0.000017666945,0.020250492,0.00009859025,0.00024769353,0.00001137778,0.00002774976,6.993301e-7,0.0015807855,0.97695094,0.00035513],"about_ca_topic_score_codex":0.000008400555,"about_ca_topic_score_gemma":0.000002484939,"teacher_disagreement_score":0.8203859,"about_ca_system_score_codex":0.0008791619,"about_ca_system_score_gemma":0.00045690197,"threshold_uncertainty_score":0.99994016},"labels":[],"label_agreement":null},{"id":"W4313463763","doi":"10.22270/ijdra.v10i4.545","title":"Regulatory Prospective on Software as a Medical Device","year":2022,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical device; Business; Software; Quality (philosophy); Process (computing); Nuclear decommissioning; Risk analysis (engineering); Engineering management; Medicine; Computer science; Engineering","score_opus":0.004316054514093103,"score_gpt":0.2227435232564608,"score_spread":0.21842746874236768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313463763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820213,0.00088314817,0.00072605896,0.002151032,0.009935938,0.00011029363,0.00001807246,0.00021423674,0.0039399536],"genre_scores_gemma":[0.99807775,0.000027523007,0.0003959826,0.00019972518,0.00088140636,0.000015753776,0.00000783479,0.000034848003,0.00035916182],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99750495,0.000041517746,0.00041034076,0.00012988575,0.0017468778,0.00016640149],"domain_scores_gemma":[0.99926084,0.00008740031,0.00011761902,0.00014380037,0.00017204996,0.00021826226],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053135917,0.00014441498,0.0001693004,0.00030474053,0.00006798634,0.000024160036,0.00060929207,0.00006278211,0.0013117557],"category_scores_gemma":[0.0001656632,0.00013873773,0.00013506139,0.00016555833,0.000060952047,0.00015327202,0.00007834313,0.00060691265,0.00003408332],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011714051,0.0023348709,0.01107727,0.00051829993,0.0049156765,0.00241819,0.013231453,0.3394846,0.0038058965,0.042660702,0.44902316,0.12935849],"study_design_scores_gemma":[0.012279325,0.0017868363,0.19924863,0.0023546552,0.00033892263,0.011132871,0.015645424,0.03133672,0.025799995,0.023739846,0.67298925,0.0033475189],"about_ca_topic_score_codex":0.000003199358,"about_ca_topic_score_gemma":0.0000017295613,"teacher_disagreement_score":0.30814788,"about_ca_system_score_codex":0.00063312973,"about_ca_system_score_gemma":0.00021217785,"threshold_uncertainty_score":0.9996012},"labels":[],"label_agreement":null},{"id":"W4313464260","doi":"10.22270/ijdra.v10i2.518","title":"A Comparative Study of Biologic Regulation in US, Canada, Australia, Europe and Singapore","year":2022,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Regulatory science; Product (mathematics); Regulatory authority; Order (exchange); Business; Quality (philosophy); Control (management); New product development; Developed country; International trade; Political science; Public administration; Marketing; Medicine; Economics; Environmental health; Management; Finance","score_opus":0.030783674348117927,"score_gpt":0.30298779999825287,"score_spread":0.27220412565013496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313464260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980291,0.000371412,0.0000055385594,0.00047404828,0.0007606968,0.00010164489,0.000029480794,0.0000023244315,0.00022574048],"genre_scores_gemma":[0.9991342,0.00000674317,0.000098215416,0.00004302012,0.000026549682,0.0000018373426,0.000005852926,0.000003886176,0.000679724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984788,0.0005563081,0.00055197877,0.00013813317,0.00016347272,0.00011135666],"domain_scores_gemma":[0.99902976,0.00014334398,0.00047851182,0.000086144755,0.00023973749,0.000022519293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068968185,0.00010099435,0.00030202817,0.00020173694,0.00005771167,0.000006946926,0.00028657643,0.000038801867,0.00042972542],"category_scores_gemma":[0.000053277017,0.00008320534,0.000045261568,0.0001504865,0.00013212113,0.000064171465,0.00013282741,0.00032764295,5.488052e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029062864,0.0029680622,0.800583,0.00002371962,0.0023988327,0.0003982603,0.006686024,0.00454458,0.15430045,0.003174354,0.019018283,0.00299816],"study_design_scores_gemma":[0.0026375675,0.0007749413,0.96429807,0.00004074673,0.00007192601,0.00033292678,0.011809189,0.000042173913,0.011288464,0.00035230856,0.008179413,0.00017229446],"about_ca_topic_score_codex":0.006406193,"about_ca_topic_score_gemma":0.026137445,"teacher_disagreement_score":0.16371505,"about_ca_system_score_codex":0.00014065746,"about_ca_system_score_gemma":0.00013024763,"threshold_uncertainty_score":0.991633},"labels":[],"label_agreement":null},{"id":"W4313464290","doi":"10.22270/ijdra.v10i2.522","title":"Analysis on the registration and review system of emergency medical devices in China and abroad in the context of COVID-19","year":2022,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Disaster Response and Management","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"China; Context (archaeology); Medical emergency; Quality (philosophy); European union; Coronavirus disease 2019 (COVID-19); Emergency management; Medicine; Business; Political science; Law; Geography; Infectious disease (medical specialty)","score_opus":0.031174747960885315,"score_gpt":0.4000642910526693,"score_spread":0.36888954309178396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313464290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96457505,0.004489794,0.00004006653,0.027066883,0.00030314687,0.00036808278,0.00001565455,0.0000023465134,0.0031390025],"genre_scores_gemma":[0.9972766,0.0014915318,0.0000041608755,0.0010121404,0.000034784956,0.000024642251,0.0000031689162,0.0000034081656,0.00014958244],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.996285,0.0016498464,0.0009533834,0.000095289884,0.0009380053,0.000078470235],"domain_scores_gemma":[0.99825656,0.00050445023,0.0009523525,0.00014547416,0.0000905079,0.00005062291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064692297,0.00006884654,0.0002597479,0.00032219096,0.00008614357,0.000003882213,0.00041466783,0.000023248835,0.00035069123],"category_scores_gemma":[0.00043948347,0.00004113167,0.00008617612,0.0002908995,0.00005339664,0.00007396589,0.00011310025,0.00029239143,3.89277e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002657912,0.0009934298,0.46344543,0.0065550515,0.003155832,0.00041393543,0.1547577,0.0011330139,0.00007431224,0.29462898,0.061886165,0.010298247],"study_design_scores_gemma":[0.0029319103,0.00028307972,0.41136712,0.005451709,0.00059109327,0.000073472715,0.5309658,0.0011573635,0.000008672205,0.0011221173,0.04584815,0.00019950084],"about_ca_topic_score_codex":0.00020944593,"about_ca_topic_score_gemma":0.0012001749,"teacher_disagreement_score":0.37620813,"about_ca_system_score_codex":0.00014230625,"about_ca_system_score_gemma":0.00023180491,"threshold_uncertainty_score":0.3839823},"labels":[],"label_agreement":null},{"id":"W4313464329","doi":"10.22270/ijdra.v10i2.514","title":"A Comparison of the Drug Approval Process in the United States and Canada","year":2022,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Drug approval; Approved drug; Food and drug administration; Population; Clinical trial; Drug; Business; Family medicine; Pharmacology; Environmental health","score_opus":0.02606590921075354,"score_gpt":0.28600587898892915,"score_spread":0.25993996977817563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313464329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869058,0.0005059629,0.000002961731,0.010725391,0.00055751204,0.00006958131,0.00011307217,0.0000010492687,0.0011186793],"genre_scores_gemma":[0.99899095,0.00003875457,0.00000856899,0.00083016965,0.00006803332,0.0000041462918,0.0000043255077,0.000006391646,0.000048635928],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990008,0.00005305839,0.0006226918,0.0000878982,0.00013485026,0.000100687794],"domain_scores_gemma":[0.99902105,0.00011537087,0.0006729389,0.000096812735,0.000057177782,0.00003661947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078438903,0.00006883163,0.00019182601,0.00017370911,0.000067358575,0.000027608776,0.0006978095,0.0000111018635,0.000070914786],"category_scores_gemma":[0.00004355947,0.000053481945,0.00006237274,0.00013262451,0.00007311102,0.00008319885,0.00009987955,0.0002918939,4.252769e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020248003,0.0004177161,0.72167724,0.00004349351,0.00035307146,0.000019657595,0.02084548,0.105933115,0.000018156012,0.12776357,0.02227779,0.00044821014],"study_design_scores_gemma":[0.0050826683,0.00012398082,0.33256072,0.00009531807,0.0000478434,0.00029903432,0.07935655,0.092815794,0.0013210578,0.103226915,0.38441893,0.0006511804],"about_ca_topic_score_codex":0.021917077,"about_ca_topic_score_gemma":0.014929733,"teacher_disagreement_score":0.38911653,"about_ca_system_score_codex":0.00019849735,"about_ca_system_score_gemma":0.00016072481,"threshold_uncertainty_score":0.9845961},"labels":[],"label_agreement":null},{"id":"W4386997085","doi":"10.22270/ijdra.v11i3.619","title":"Comparative study of Regulatory requirement for preparation of Dossier for Registration of Veterinary Drug in US, EU and Canada","year":2023,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Animal testing and alternatives","field":"Veterinary","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Timeline; Veterinary drug; Eu countries; Political science; Veterinary medicine; Drug approval; Veterinary Drugs; European union; Regulatory affairs; Medicine; Business; Public administration; Drug; Geography; Pharmacology; International trade","score_opus":0.11808932590784996,"score_gpt":0.4127227219144452,"score_spread":0.2946333960065952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386997085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985606,0.0001170178,0.000051708193,0.00012764201,0.0003779557,0.0005007419,0.00008049638,0.000007688037,0.0001761329],"genre_scores_gemma":[0.99908674,0.000010339682,0.00053939916,0.0000054499037,0.00012482185,0.000023065026,0.00001272891,0.000014413395,0.00018305256],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99776214,0.00012809206,0.0011461496,0.00019072721,0.0006484526,0.00012441212],"domain_scores_gemma":[0.9970212,0.00045445532,0.0015667259,0.00014234963,0.00076851243,0.00004678043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001062497,0.00014287821,0.00041758464,0.00029539244,0.00003683891,0.000011119878,0.00026814532,0.000031862084,0.0000066873263],"category_scores_gemma":[0.0001545679,0.00013750841,0.00009579478,0.000117976946,0.00011127124,0.0002760745,0.00005988369,0.00008203736,9.121384e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.065712966,0.0058370247,0.20502336,0.0025804446,0.00581046,0.00043852467,0.1143389,0.038927227,0.5131869,0.010602871,0.03267161,0.0048697055],"study_design_scores_gemma":[0.01209858,0.012135004,0.82274306,0.0021397914,0.00022775713,0.00018287127,0.07729726,0.014435757,0.054336686,0.0023835383,0.0014141042,0.0006055873],"about_ca_topic_score_codex":0.0048002684,"about_ca_topic_score_gemma":0.009425135,"teacher_disagreement_score":0.6177197,"about_ca_system_score_codex":0.00017432804,"about_ca_system_score_gemma":0.00030147613,"threshold_uncertainty_score":0.7256602},"labels":[],"label_agreement":null},{"id":"W4386997187","doi":"10.22270/ijdra.v11i3.613","title":"Similarities and differences in filing for Drug Master File in US, Canada and Europe","year":2023,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"American Sleep Medicine Foundation","keywords":"Discretion; Confidentiality; Business; Database; Computer science; Law; Computer security; Political science","score_opus":0.037005608732142564,"score_gpt":0.24562269380943796,"score_spread":0.2086170850772954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386997187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937678,0.00058170414,0.000003327911,0.003355079,0.00046937642,0.00005407107,0.00056205055,0.0000028160434,0.0012037902],"genre_scores_gemma":[0.99841875,0.00044568354,0.000068373476,0.00033841046,0.00012774424,0.0000040292703,0.000009593903,0.000009572444,0.00057785516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916667,0.000011753857,0.0005100534,0.00012714189,0.000042696178,0.00014165753],"domain_scores_gemma":[0.99941516,0.00023023157,0.00021217893,0.000044874392,0.0000311661,0.000066394394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040431094,0.00007927762,0.00021956266,0.00032474424,0.000020193564,0.0000586335,0.00016223456,0.000023618551,0.00013873972],"category_scores_gemma":[0.000107745174,0.00008601268,0.000032184704,0.00007279343,0.00004390207,0.00018839163,0.0000596487,0.00011906209,0.000002583817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001448938,0.000059392616,0.91550523,0.00009657236,0.00016616227,0.00009632777,0.0018148748,0.0009165059,0.000024113882,0.038547415,0.0405977,0.0020308336],"study_design_scores_gemma":[0.0017880624,0.000022974908,0.8819018,0.00015157452,0.000004416349,0.000025479812,0.0009568599,0.017708741,0.00008387994,0.02455716,0.07253766,0.0002614078],"about_ca_topic_score_codex":0.0060708686,"about_ca_topic_score_gemma":0.047576208,"teacher_disagreement_score":0.04150534,"about_ca_system_score_codex":0.00009326134,"about_ca_system_score_gemma":0.00006926527,"threshold_uncertainty_score":0.96980304},"labels":[],"label_agreement":null},{"id":"W4390571917","doi":"10.22270/ijdra.v11i4.633","title":"A Review on Next Generation eCTD – eCTD v4.0","year":2023,"lang":"en","type":"review","venue":"International Journal of Drug Regulatory Affairs","topic":"Quality and Safety in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Certification; XML; Process (computing); Business; Regulatory authority; Computer science; Information exchange; Product (mathematics); Accounting; World Wide Web; Political science; Telecommunications; Public administration; Law","score_opus":0.3663792009933086,"score_gpt":0.5315893539655137,"score_spread":0.16521015297220504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390571917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003200171,0.97899455,0.000013633816,0.0046505416,0.012867697,0.0012935536,0.00016783352,0.00008662082,0.0018935641],"genre_scores_gemma":[0.00010458442,0.98542076,0.00006473525,0.002221294,0.008120665,0.00012041066,0.00023629409,0.0001325912,0.003578662],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9897596,0.003405767,0.004163579,0.00046195052,0.0016881974,0.00052090123],"domain_scores_gemma":[0.99079096,0.0020034488,0.004613196,0.0006238595,0.0016192707,0.00034926474],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005215566,0.0005715042,0.002332401,0.0008245335,0.00040040942,0.000042075004,0.0013911788,0.00062433945,0.000737845],"category_scores_gemma":[0.0014456755,0.00044708504,0.0013091505,0.00044489928,0.00008993937,0.00036464035,0.00020984045,0.0028420805,0.0017789439],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007389279,0.00010052123,0.000009649678,0.10156777,0.0016140866,0.00029377872,0.001662438,0.000021971491,0.000001133747,0.007641303,0.41723117,0.4697823],"study_design_scores_gemma":[0.00029699496,0.000062481835,0.0000048811626,0.23432933,0.00039994344,0.00010023455,0.00070168584,0.0000120698505,3.3738155e-7,0.0003215928,0.76349276,0.00027767528],"about_ca_topic_score_codex":0.000027754697,"about_ca_topic_score_gemma":0.00008775953,"teacher_disagreement_score":0.4695046,"about_ca_system_score_codex":0.0016805754,"about_ca_system_score_gemma":0.003059235,"threshold_uncertainty_score":0.9997981},"labels":[],"label_agreement":null},{"id":"W4390572338","doi":"10.22270/ijdra.v11i4.631","title":"A Review on Approval and Registration Process of Medical Devices in Canada and India","year":2023,"lang":"en","type":"review","venue":"International Journal of Drug Regulatory Affairs","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada; Canadian Institutes of Health Research","funders":"","keywords":"Business; Health technology; Population; Medicine; Health care; Order (exchange); Marketing; Medical emergency; Finance; Environmental health; Economic growth","score_opus":0.05931262392609347,"score_gpt":0.34678687639898353,"score_spread":0.28747425247289005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390572338","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027563393,0.9943492,9.361109e-7,0.0012649695,0.00045785177,0.00017120394,0.00013108189,0.0000021680778,0.00086624495],"genre_scores_gemma":[0.016601259,0.9827795,0.000008909643,0.00036149498,0.000185549,0.000007687225,0.000010172245,0.000020293162,0.000025111432],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977086,0.00003952834,0.001712509,0.00021439594,0.00019832671,0.0001266379],"domain_scores_gemma":[0.9975163,0.00020829354,0.0019569106,0.00010396011,0.00006335963,0.0001512094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014510524,0.0001793119,0.0011468404,0.0004086367,0.000012547646,0.00002931265,0.0004787018,0.000109478104,0.000049571845],"category_scores_gemma":[0.00030377248,0.0001688237,0.00013368097,0.00013677336,0.00006772591,0.00013265834,0.000066649634,0.00040365855,0.0000046379687],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007505041,0.00021815028,0.0046341857,0.092164725,0.0021451474,0.0003465085,0.00050931127,0.000038212966,5.110343e-8,0.11916475,0.01120317,0.76950073],"study_design_scores_gemma":[0.0007515826,0.00004091403,0.0012124776,0.0658865,0.00010514327,0.0002881244,0.00012369534,0.00020289485,8.782562e-7,0.0046267095,0.92638063,0.00038047743],"about_ca_topic_score_codex":0.011328008,"about_ca_topic_score_gemma":0.0406322,"teacher_disagreement_score":0.91517746,"about_ca_system_score_codex":0.0003434882,"about_ca_system_score_gemma":0.0012483608,"threshold_uncertainty_score":0.99525565},"labels":[],"label_agreement":null},{"id":"W4393390818","doi":"10.22270/ijdra.v12i1.654","title":"Overview of Post-approval Submissions Management in US, Europe and Canada","year":2024,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Political science; Library science; Geography; Computer science","score_opus":0.11527210434906467,"score_gpt":0.37307770650916056,"score_spread":0.2578056021600959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393390818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.943846,0.015258851,0.00010244536,0.031693514,0.0024517095,0.00019766769,0.0001685986,0.00000914314,0.0062720976],"genre_scores_gemma":[0.9965418,0.0009503857,0.0006630479,0.00088858296,0.00020514659,0.000003529402,0.0000059842314,0.000017873046,0.00072364975],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9967702,0.00012071277,0.0025286672,0.00020483331,0.00023356338,0.00014200498],"domain_scores_gemma":[0.99826664,0.00027139127,0.0010265486,0.0001455862,0.00017326808,0.00011658151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047028237,0.00011028314,0.0004252569,0.00053303194,0.000024679925,0.000052292227,0.00032448972,0.000036688612,0.00018557854],"category_scores_gemma":[0.00038341133,0.00012179309,0.00008481458,0.0001229927,0.00004617379,0.00037323654,0.00007356517,0.00016164639,0.000019804842],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012797392,0.00027598112,0.10667682,0.002005529,0.0016839268,0.000457959,0.003559802,0.0017279211,0.00006377485,0.7880133,0.090528235,0.0048788115],"study_design_scores_gemma":[0.0020900213,0.00009932164,0.5464121,0.0027354625,0.000047797657,0.00031203064,0.0059844963,0.0041912813,0.00008052262,0.013441786,0.42404315,0.0005620142],"about_ca_topic_score_codex":0.01904016,"about_ca_topic_score_gemma":0.023251433,"teacher_disagreement_score":0.7745715,"about_ca_system_score_codex":0.0005364522,"about_ca_system_score_gemma":0.0004577606,"threshold_uncertainty_score":0.9945717},"labels":[],"label_agreement":null},{"id":"W4393393898","doi":"10.22270/ijdra.v12i1.624","title":"Nitrosamine Contamination in Pharmaceuticals: Regulatory Perspectives and Control Strategies of USFDA, EMA & HC","year":2024,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Chemical Analysis and Environmental Impact","field":"Environmental Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Contamination; Business; Chemistry; Biotechnology; Biology; Ecology","score_opus":0.007917743006577903,"score_gpt":0.27616596459668186,"score_spread":0.268248221590104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393393898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364144,0.0035567512,0.00027148964,0.0008990794,0.00016758004,0.00006403827,0.0000141514265,0.000008189196,0.0013772569],"genre_scores_gemma":[0.9990105,0.00042197396,0.00019105268,0.000022903698,0.00010398369,0.0000017110673,0.000003229541,0.0000118340295,0.00023282436],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984067,0.00006997034,0.00052516855,0.00019693718,0.0006586577,0.00014258143],"domain_scores_gemma":[0.9994131,0.00014255077,0.00020671995,0.000094062816,0.000033085442,0.000110499444],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055846164,0.00014184816,0.00025112304,0.00017217836,0.000020217227,0.00006541523,0.00022700468,0.000051737374,0.0010248928],"category_scores_gemma":[0.00005063388,0.00011723428,0.00015335337,0.00012562913,0.00042192388,0.000711998,0.00007582898,0.00020230262,0.000015014407],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046570972,0.00092614105,0.08823945,0.000075121294,0.0009973529,0.00019477439,0.0067005022,0.007448193,0.86219674,0.0030254615,0.0024715965,0.027258938],"study_design_scores_gemma":[0.0054730074,0.0002798948,0.8536357,0.00095689914,0.00047404642,0.000590024,0.02966311,0.00933501,0.076467454,0.0107770255,0.011578458,0.0007693325],"about_ca_topic_score_codex":0.00003316503,"about_ca_topic_score_gemma":0.000053576376,"teacher_disagreement_score":0.7857293,"about_ca_system_score_codex":0.000377419,"about_ca_system_score_gemma":0.000025396805,"threshold_uncertainty_score":0.9998883},"labels":[],"label_agreement":null},{"id":"W4403169632","doi":"10.22270/ijdra.v12i3.699","title":"Index of application status transparency and availability of public information for Project Orbis agencies","year":2024,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Geographic Information Systems Studies","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Government of Canada","funders":"Health Canada; U.S. Food and Drug Administration","keywords":"Transparency (behavior); Index (typography); Business; Public administration; Political science; Computer science; Computer security; World Wide Web","score_opus":0.02176827848225863,"score_gpt":0.307281380863256,"score_spread":0.28551310238099736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403169632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9683737,0.0015398898,0.016432777,0.0016818293,0.0014646413,0.0008362657,0.0001865691,0.0000417715,0.009442526],"genre_scores_gemma":[0.9991839,0.00027014277,0.00035440468,0.0000072593302,0.000098062505,0.000019646603,0.000008404212,0.0000037699824,0.00005439792],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9979904,0.00006918826,0.0009319813,0.00006976977,0.00080864993,0.00012998805],"domain_scores_gemma":[0.99722487,0.00020412185,0.0007039296,0.00008010189,0.0017362693,0.000050736995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021231964,0.00007963618,0.00018722092,0.0005738083,0.0000838181,0.00007587539,0.00024053061,0.00005729034,0.000013526585],"category_scores_gemma":[0.00029966445,0.000069735775,0.00013486887,0.00026654257,0.00033890014,0.0017261107,0.000023702169,0.00007823509,8.504594e-7],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026928622,0.00015159273,0.17228803,0.0017072114,0.001555313,0.0000014774067,0.40835667,0.00027636858,0.00065670046,0.29428604,0.004098565,0.11635276],"study_design_scores_gemma":[0.002419069,0.0003018187,0.15778282,0.00095470756,0.0002018329,0.000035159934,0.5055368,0.0028302076,0.0022250167,0.021393526,0.30579805,0.0005209773],"about_ca_topic_score_codex":0.00026029412,"about_ca_topic_score_gemma":0.00024883344,"teacher_disagreement_score":0.3016995,"about_ca_system_score_codex":0.00015225874,"about_ca_system_score_gemma":0.00055114285,"threshold_uncertainty_score":0.28437424},"labels":[],"label_agreement":null},{"id":"W4403169648","doi":"10.22270/ijdra.v12i3.680","title":"Post-approval changes in Labelling regulations in the United States, European Union and Canada","year":2024,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Consumer Attitudes and Food Labeling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"European union; Labelling; International trade; Political science; Business; Psychology; Criminology","score_opus":0.01149745353016584,"score_gpt":0.25296381770849513,"score_spread":0.24146636417832928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403169648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719383,0.0030339744,0.00003266764,0.024046998,0.0004595107,0.000086312866,0.000012644859,0.000008252272,0.000381297],"genre_scores_gemma":[0.99895644,0.0002697579,0.00012423728,0.00030134997,0.00018389037,9.3275327e-7,0.000030346797,0.0000140447455,0.0001189744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988548,0.00016247956,0.00032891787,0.00010888523,0.00043464458,0.00011027038],"domain_scores_gemma":[0.9994129,0.00015319302,0.000086073946,0.00008330594,0.00021027094,0.00005428293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011783204,0.0000895633,0.00012161049,0.00045816324,0.00002577931,0.00005990741,0.00015625698,0.000020187543,0.00001753403],"category_scores_gemma":[0.000050801,0.000065021115,0.000033080676,0.00019826279,0.000041325107,0.000093873525,0.0000334135,0.00030780243,6.5363014e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019897467,0.0016782344,0.4024726,0.0016249466,0.0070393775,0.038678676,0.10645452,0.050139446,0.029020028,0.030635992,0.015429022,0.31483743],"study_design_scores_gemma":[0.0059494446,0.0004199472,0.7595457,0.007371036,0.00057766703,0.0055122995,0.040830735,0.034899406,0.0010292258,0.0009776191,0.1421947,0.0006922532],"about_ca_topic_score_codex":0.026330018,"about_ca_topic_score_gemma":0.26218936,"teacher_disagreement_score":0.3570731,"about_ca_system_score_codex":0.0001888004,"about_ca_system_score_gemma":0.00024982943,"threshold_uncertainty_score":0.98015374},"labels":[],"label_agreement":null},{"id":"W4405847843","doi":"10.22270/ijdra.v12i4.724","title":"Comparison of GMP for Drugs in EU, US, Canada, WHO and Australia","year":2024,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Good manufacturing practice; Business; European union; Sanitation; Quality (philosophy); Product (mathematics); Production (economics); International trade; Marketing; Medicine; Economics","score_opus":0.047135678910785586,"score_gpt":0.40881887362515945,"score_spread":0.3616831947143739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405847843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825261,0.0041090674,0.000016110647,0.011294543,0.0010265113,0.00009563193,0.000023849478,0.0000033846259,0.00090478937],"genre_scores_gemma":[0.9987194,0.00014859939,0.00019340705,0.00011010416,0.00028519647,0.0000015775402,0.0000020330613,0.000007470231,0.0005321926],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988942,0.000024765963,0.0004505524,0.000089655325,0.00043748604,0.00010329791],"domain_scores_gemma":[0.99916327,0.00031148447,0.00017514924,0.000042155094,0.00021336314,0.000094604125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003810127,0.00007921984,0.00026215988,0.00011637086,0.000016425556,0.000020712609,0.000102499595,0.000028854172,0.00007051651],"category_scores_gemma":[0.00009359779,0.000063253945,0.000075464945,0.00006058744,0.00006220269,0.00014654505,0.000029575207,0.00020886742,5.543578e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004125085,0.0006812455,0.63931936,0.0013467824,0.0044740844,0.00062771066,0.007421624,0.00057228684,0.0063481634,0.01639648,0.2780823,0.040604882],"study_design_scores_gemma":[0.003800577,0.00031332512,0.352823,0.0020741122,0.00045067706,0.00034914786,0.0071511515,0.0041203764,0.015717844,0.0007689778,0.61218125,0.0002495917],"about_ca_topic_score_codex":0.00435097,"about_ca_topic_score_gemma":0.010592019,"teacher_disagreement_score":0.3340989,"about_ca_system_score_codex":0.00017387122,"about_ca_system_score_gemma":0.00023018359,"threshold_uncertainty_score":0.6577394},"labels":[],"label_agreement":null},{"id":"W4413299648","doi":"10.22270/ijdra.v13i1.735","title":"Comparative Study of Medical Device Regulation in US, EU and Canada","year":2025,"lang":"en","type":"article","venue":"International Journal of Drug Regulatory Affairs","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Political science; Business; International trade","score_opus":0.014259337278858364,"score_gpt":0.32805686753826435,"score_spread":0.313797530259406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413299648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808422,0.00037571735,0.00006240669,0.017001191,0.00067075156,0.00015277632,0.0000022437769,0.000003235973,0.0008895296],"genre_scores_gemma":[0.99934584,0.00004258448,0.00009425303,0.00023889772,0.00011691319,0.0000013678745,0.0000042991583,0.0000046351834,0.00015120216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723005,0.00010838016,0.00075609144,0.00012583069,0.0016921504,0.000087466105],"domain_scores_gemma":[0.9986258,0.0001678443,0.00035334483,0.000099168545,0.00063001405,0.00012380065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009241798,0.00009661235,0.0003544075,0.00037127102,0.00002382633,0.00001114469,0.0002014724,0.00011002677,0.000060286555],"category_scores_gemma":[0.0001212769,0.00007689386,0.000045961264,0.0001835852,0.00023275688,0.0000933542,0.000067281304,0.0003544995,1.7350654e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004745277,0.006363557,0.83930993,0.0006774798,0.005163435,0.0013755491,0.020639233,0.0025725744,0.006233492,0.052257903,0.02279853,0.03786305],"study_design_scores_gemma":[0.0050553605,0.00016238607,0.9758032,0.0010810477,0.00009273987,0.00011998701,0.010058077,0.0026916885,0.0012143682,0.0009203845,0.0027118912,0.0000888975],"about_ca_topic_score_codex":0.022161966,"about_ca_topic_score_gemma":0.19603246,"teacher_disagreement_score":0.1738705,"about_ca_system_score_codex":0.00024120968,"about_ca_system_score_gemma":0.001438899,"threshold_uncertainty_score":0.98434955},"labels":[],"label_agreement":null}]}